Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Options
Two new option listings and three option delistings on October 26th » 08:30
10/26/20
10/26
08:30
10/26/20
08:30
AAIC

Advanced Aerodynamics

$2.73 /

+0.1 (+3.80%)

, RIDE

Lordstown Motors

$0.00 /

+ (+0.00%)

, AI

Arlington Asset Investment

/

+

, DPHC

DiamondPeak Holdings

$18.23 /

-2.2 (-10.77%)

, IMMU

Acquired by GILD

$87.86 /

+ (+0.00%)

New option listings for…

New option listings for October 26th include Arlington Asset Investment Corp (Class A Stock) (AAIC) and Lordstown Motors Corporation (Class A Stock) (RIDE). Option delistings effective October 26th include Arlington Asset Investment Corp (Class A Stock) (AI), DiamondPeak Holdings Corporation (Class A Stock) (DPHC), and Immunomedics Inc (IMMU).

ShowHide Related Items >><<
RIDE Lordstown Motors
$0.00 /

+ (+0.00%)

IMMU Acquired by GILD
$87.86 /

+ (+0.00%)

DPHC DiamondPeak Holdings
$18.23 /

-2.2 (-10.77%)

AI Arlington Asset Investment
/

+

AAIC Advanced Aerodynamics
$2.73 /

+0.1 (+3.80%)

RIDE Lordstown Motors
$0.00 /

+ (+0.00%)

10/12/20 BTIG
DiamondPeak Holdings initiated with a Buy at BTIG
09/18/20 Colliers
Lordstown's presentation raised Colliers' expectations for Workhorse valuation
09/17/20 Roth Capital
Roth raises Workhorse target to $33 after Lordstown's 'compelling' analyst day
AI Arlington Asset Investment
/

+

03/27/20 Ladenburg
Arlington Asset Investment downgraded to Neutral from Buy at Ladenburg
01/14/20 JonesTrading
Arlington Asset Investment initiated with a Buy at JonesTrading
DPHC DiamondPeak Holdings
$18.23 /

-2.2 (-10.77%)

09/03/20 Oppenheimer
Oppenheimer bullish on Workhorse Group, initiates with an Outperform
IMMU Acquired by GILD
$87.86 /

+ (+0.00%)

09/21/20 BofA
Axalta Coating added to US 1 List at BofA
09/20/20 Citi
Immunomedics presents at ESMO, readouts exceeded expectations, says Citi
09/20/20 Piper Sandler
Immunomedics ASCENT data 'an absolute slam dunk,' says Piper Sandler
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
IMMU Acquired by GILD
$87.86 /

+ (+0.00%)

AI Arlington Asset Investment
/

+

  • 29
    Apr
  • 05
    Dec
RIDE Lordstown Motors
$0.00 /

+ (+0.00%)

IMMU Acquired by GILD
$87.86 /

+ (+0.00%)

DPHC DiamondPeak Holdings
$18.23 /

-2.2 (-10.77%)

RIDE Lordstown Motors
$0.00 /

+ (+0.00%)

IMMU Acquired by GILD
$87.86 /

+ (+0.00%)

DPHC DiamondPeak Holdings
$18.23 /

-2.2 (-10.77%)

AI Arlington Asset Investment
/

+

IMMU Acquired by GILD
$87.86 /

+ (+0.00%)

DPHC DiamondPeak Holdings
$18.23 /

-2.2 (-10.77%)

Hot Stocks
Knight signs exclusive AmBisome agreement with Gilead in Brazil » 07:45
10/26/20
10/26
07:45
10/26/20
07:45
GILD

Gilead

$60.80 /

+0.12 (+0.20%)

Knight Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GILD Gilead
$60.80 /

+0.12 (+0.20%)

GILD Gilead
$60.80 /

+0.12 (+0.20%)

10/22/20 Piper Sandler
Approval of Gilead's Veklury confirms FDA confidence, says Piper Sandler
10/16/20 Baird
Baird negative on Gilead clinical data for remdesivir
10/16/20 Citi
Gilead investors may start questioning Galapagos collaboration, says Citi
09/30/20 Jefferies
Regeneron antibody cocktail results positive for vaccines, says Jefferies
GILD Gilead
$60.80 /

+0.12 (+0.20%)

GILD Gilead
$60.80 /

+0.12 (+0.20%)

GILD Gilead
$60.80 /

+0.12 (+0.20%)

GILD Gilead
$60.80 /

+0.12 (+0.20%)

Friday
On The Fly
Fly Intel: Wall Street's top stories for Friday » 16:33
10/23/20
10/23
16:33
10/23/20
16:33
INTC

Intel

$48.20 /

-5.78 (-10.71%)

, AXP

American Express

$100.99 /

-3.81 (-3.64%)

, GILD

Gilead

$60.80 /

+0.12 (+0.20%)

, AZN

AstraZeneca

$52.01 /

+0.03 (+0.06%)

, JNJ

Johnson & Johnson

$145.31 /

+0.14 (+0.10%)

, MAT

Mattel

$14.16 /

+1.23 (+9.51%)

, BCS

Barclays

$5.83 /

+0.33 (+6.00%)

, COF

Capital One

$78.00 /

+1.02 (+1.33%)

, STX

Seagate

$50.74 /

-1.06 (-2.05%)

, LLNW

Limelight Networks

$4.19 /

-1.99 (-32.20%)

, BLMN

Bloomin' Brands

$16.27 /

-1.45 (-8.18%)

The major averages…

ShowHide Related Items >><<
STX Seagate
$50.74 /

-1.06 (-2.05%)

MAT Mattel
$14.16 /

+1.23 (+9.51%)

LLNW Limelight Networks
$4.19 /

-1.99 (-32.20%)

JNJ Johnson & Johnson
$145.31 /

+0.14 (+0.10%)

INTC Intel
$48.20 /

-5.78 (-10.71%)

GILD Gilead
$60.80 /

+0.12 (+0.20%)

COF Capital One
$78.00 /

+1.02 (+1.33%)

BLMN Bloomin' Brands
$16.27 /

-1.45 (-8.18%)

BCS Barclays
$5.83 /

+0.33 (+6.00%)

AZN AstraZeneca
$52.01 /

+0.03 (+0.06%)

AXP American Express
$100.99 /

-3.81 (-3.64%)

INTC Intel
$48.20 /

-5.78 (-10.71%)

10/23/20
Fly Intel: Top five analyst downgrades
10/23/20 Truist
Intel price target lowered to $51 from $61 at Truist
10/23/20 Jefferies
TSMC clearly has 'stronger hand' if Intel comes to negotiate, says Jefferies
10/23/20 JPMorgan
Intel price target lowered to $70 from $75 at JPMorgan
AXP American Express
$100.99 /

-3.81 (-3.64%)

10/09/20
Fly Intel: Top five analyst downgrades
10/09/20 JPMorgan
American Express price target raised to $106 from $97 at JPMorgan
10/09/20 Susquehanna
American Express downgraded to Neutral from Positive at Susquehanna
09/23/20
Fly Intel: Top five analyst downgrades
GILD Gilead
$60.80 /

+0.12 (+0.20%)

10/22/20 Piper Sandler
Approval of Gilead's Veklury confirms FDA confidence, says Piper Sandler
10/16/20 Baird
Baird negative on Gilead clinical data for remdesivir
10/16/20 Citi
Gilead investors may start questioning Galapagos collaboration, says Citi
09/30/20 Jefferies
Regeneron antibody cocktail results positive for vaccines, says Jefferies
AZN AstraZeneca
$52.01 /

+0.03 (+0.06%)

10/23/20 Stifel
FibroGen safety data mitigates concerns of roxadustat black box, says Stifel
10/08/20 JPMorgan
AstraZeneca FY20 guide could look conservative after Q3 results, says JPMorgan
10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
09/29/20 Berenberg
AstraZeneca initiated with a Buy at Berenberg
JNJ Johnson & Johnson
$145.31 /

+0.14 (+0.10%)

10/14/20 Credit Suisse
Johnson & Johnson price target raised to $168 from $163 at Credit Suisse
10/14/20 Cantor Fitzgerald
Johnson & Johnson price target raised to $180 from $168 at Cantor Fitzgerald
10/13/20 Wells Fargo
Emergent selloff on J&J study pause an overreaction, says Wells Fargo
MAT Mattel
$14.16 /

+1.23 (+9.51%)

10/23/20
Fly Intel: Top five analyst upgrades
10/23/20 JPMorgan
Mattel price target raised to $20 from $17.50 at JPMorgan
10/23/20 JPMorgan
Hasbro price target raised to $92 from $83 at JPMorgan
10/23/20 DA Davidson
Mattel upgraded to Buy at DA Davidson after 'outstanding' Q3 results
BCS Barclays
$5.83 /

+0.33 (+6.00%)

10/06/20 Redburn
Barclays upgraded to Buy from Sell at Redburn
08/07/20 AlphaValue
Barclays upgraded to Reduce from Sell at AlphaValue
07/14/20 Deutsche Bank
Barclays price target lowered to 135 GBp from 208 GBp at Deutsche Bank
07/10/20 Investec
Barclays upgraded to Buy from Hold at Investec
COF Capital One
$78.00 /

+1.02 (+1.33%)

10/23/20 RBC Capital
Capital One price target raised to $82 from $72 at RBC Capital
10/23/20 Wells Fargo
Capital One price target raised to $100 from $90 at Wells Fargo
10/09/20 JPMorgan
Capital One price target raised to $86.50 from $72 at JPMorgan
07/31/20 Wolfe Research
Capital One initiated with an Outperform at Wolfe Research
STX Seagate
$50.74 /

-1.06 (-2.05%)

10/23/20 Craig-Hallum
Seagate price target raised to $65 from $60 at Craig-Hallum
10/23/20 Loop Capital
Seagate price target raised to $60 from $55 at Loop Capital
10/23/20 Susquehanna
Seagate price target raised to $40 from $37 at Susquehanna
LLNW Limelight Networks
$4.19 /

-1.99 (-32.20%)

10/23/20 Craig-Hallum
Limelight Networks downgraded to Hold from Buy at Craig-Hallum
10/23/20 B. Riley Securities
Limelight Networks price target lowered to $7 from $9 at B. Riley Securities
10/23/20 Northland
Limelight Networks downgraded to Market Perform from Outperform at Northland
10/15/20 DA Davidson
Fastly price target lowered to $105 from $115 at DA Davidson
BLMN Bloomin' Brands
$16.27 /

-1.45 (-8.18%)

10/20/20 JPMorgan
Bloomin' Brands price target raised to $20 from $16 at JPMorgan
09/14/20 Raymond James
Bloomin' Brands price target raised to $20 from $18 at Raymond James
09/01/20
Fly Intel: Top five analyst upgrades
09/01/20 Raymond James
Raymond James upgrades casual restaurant laggard Bloomin' Brands to Strong Buy
STX Seagate
$50.74 /

-1.06 (-2.05%)

MAT Mattel
$14.16 /

+1.23 (+9.51%)

LLNW Limelight Networks
$4.19 /

-1.99 (-32.20%)

JNJ Johnson & Johnson
$145.31 /

+0.14 (+0.10%)

INTC Intel
$48.20 /

-5.78 (-10.71%)

GILD Gilead
$60.80 /

+0.12 (+0.20%)

COF Capital One
$78.00 /

+1.02 (+1.33%)

BLMN Bloomin' Brands
$16.27 /

-1.45 (-8.18%)

BCS Barclays
$5.83 /

+0.33 (+6.00%)

AZN AstraZeneca
$52.01 /

+0.03 (+0.06%)

AXP American Express
$100.99 /

-3.81 (-3.64%)

STX Seagate
$50.74 /

-1.06 (-2.05%)

JNJ Johnson & Johnson
$145.31 /

+0.14 (+0.10%)

INTC Intel
$48.20 /

-5.78 (-10.71%)

GILD Gilead
$60.80 /

+0.12 (+0.20%)

COF Capital One
$78.00 /

+1.02 (+1.33%)

BCS Barclays
$5.83 /

+0.33 (+6.00%)

AZN AstraZeneca
$52.01 /

+0.03 (+0.06%)

AXP American Express
$100.99 /

-3.81 (-3.64%)

JNJ Johnson & Johnson
$145.31 /

+0.14 (+0.10%)

INTC Intel
$48.20 /

-5.78 (-10.71%)

GILD Gilead
$60.80 /

+0.12 (+0.20%)

BLMN Bloomin' Brands
$16.27 /

-1.45 (-8.18%)

BCS Barclays
$5.83 /

+0.33 (+6.00%)

AZN AstraZeneca
$52.01 /

+0.03 (+0.06%)

AXP American Express
$100.99 /

-3.81 (-3.64%)

STX Seagate
$50.74 /

-1.06 (-2.05%)

MAT Mattel
$14.16 /

+1.23 (+9.51%)

LLNW Limelight Networks
$4.19 /

-1.99 (-32.20%)

JNJ Johnson & Johnson
$145.31 /

+0.14 (+0.10%)

INTC Intel
$48.20 /

-5.78 (-10.71%)

GILD Gilead
$60.80 /

+0.12 (+0.20%)

COF Capital One
$78.00 /

+1.02 (+1.33%)

BLMN Bloomin' Brands
$16.27 /

-1.45 (-8.18%)

BCS Barclays
$5.83 /

+0.33 (+6.00%)

AZN AstraZeneca
$52.01 /

+0.03 (+0.06%)

AXP American Express
$100.99 /

-3.81 (-3.64%)

On The Fly
Fly Intel: Wall Street's top stories at midday » 12:26
10/23/20
10/23
12:26
10/23/20
12:26
INTC

Intel

$48.06 /

-5.92 (-10.97%)

, NVDA

Nvidia

$537.90 /

+4.08 (+0.76%)

, AMD

AMD

$81.05 /

+1.63 (+2.05%)

, AXP

American Express

$101.55 /

-3.25 (-3.10%)

, GILD

Gilead

$61.44 /

+0.76 (+1.25%)

, MAT

Mattel

$14.51 /

+1.58 (+12.22%)

, BCS

Barclays

$5.78 /

+0.28 (+5.09%)

, COF

Capital One

$77.64 /

+0.66 (+0.86%)

, STX

Seagate

$50.73 /

-1.07 (-2.07%)

, LLNW

Limelight Networks

$4.37 /

-1.815 (-29.37%)

, BLMN

Bloomin' Brands

$15.65 /

-2.07 (-11.68%)

The major averages are…

ShowHide Related Items >><<
STX Seagate
$50.73 /

-1.07 (-2.07%)

NVDA Nvidia
$537.90 /

+4.08 (+0.76%)

MAT Mattel
$14.51 /

+1.58 (+12.22%)

LLNW Limelight Networks
$4.37 /

-1.815 (-29.37%)

INTC Intel
$48.06 /

-5.92 (-10.97%)

GILD Gilead
$61.44 /

+0.76 (+1.25%)

COF Capital One
$77.64 /

+0.66 (+0.86%)

BLMN Bloomin' Brands
$15.65 /

-2.07 (-11.68%)

BCS Barclays
$5.78 /

+0.28 (+5.09%)

AXP American Express
$101.55 /

-3.25 (-3.10%)

AMD AMD
$81.05 /

+1.63 (+2.05%)

INTC Intel
$48.06 /

-5.92 (-10.97%)

10/23/20
Fly Intel: Top five analyst downgrades
10/23/20 Truist
Intel price target lowered to $51 from $61 at Truist
10/23/20 Jefferies
TSMC clearly has 'stronger hand' if Intel comes to negotiate, says Jefferies
10/23/20 JPMorgan
Intel price target lowered to $70 from $75 at JPMorgan
NVDA Nvidia
$537.90 /

+4.08 (+0.76%)

10/23/20 BofA
Intel downgraded to Underperform from Neutral at BofA
10/12/20 Truist
Nvidia price target raised to $623 from $550 at Truist
10/12/20 Truist
AMD initiated with a Hold at Truist
10/09/20
Fly Intel: Top five analyst downgrades
AMD AMD
$81.05 /

+1.63 (+2.05%)

10/23/20 Citi
Intel price target lowered to $50 from $53 at Citi
10/22/20 Wells Fargo
Xilinx price target raised to $110 from $100 at Wells Fargo
10/22/20 Morgan Stanley
Xilinx price target raised to $137 from $117 at Morgan Stanley
AXP American Express
$101.55 /

-3.25 (-3.10%)

10/09/20 JPMorgan
American Express price target raised to $106 from $97 at JPMorgan
10/09/20 Susquehanna
American Express downgraded to Neutral from Positive at Susquehanna
09/23/20
Fly Intel: Top five analyst downgrades
GILD Gilead
$61.44 /

+0.76 (+1.25%)

10/22/20 Piper Sandler
Approval of Gilead's Veklury confirms FDA confidence, says Piper Sandler
10/16/20 Baird
Baird negative on Gilead clinical data for remdesivir
10/16/20 Citi
Gilead investors may start questioning Galapagos collaboration, says Citi
09/30/20 Jefferies
Regeneron antibody cocktail results positive for vaccines, says Jefferies
MAT Mattel
$14.51 /

+1.58 (+12.22%)

10/23/20
Fly Intel: Top five analyst upgrades
10/23/20 JPMorgan
Mattel price target raised to $20 from $17.50 at JPMorgan
10/23/20 JPMorgan
Hasbro price target raised to $92 from $83 at JPMorgan
10/23/20 DA Davidson
Mattel upgraded to Buy at DA Davidson after 'outstanding' Q3 results
BCS Barclays
$5.78 /

+0.28 (+5.09%)

10/06/20 Redburn
Barclays upgraded to Buy from Sell at Redburn
08/07/20 AlphaValue
Barclays upgraded to Reduce from Sell at AlphaValue
07/14/20 Deutsche Bank
Barclays price target lowered to 135 GBp from 208 GBp at Deutsche Bank
07/10/20 Investec
Barclays upgraded to Buy from Hold at Investec
COF Capital One
$77.64 /

+0.66 (+0.86%)

10/23/20 RBC Capital
Capital One price target raised to $82 from $72 at RBC Capital
10/23/20 Wells Fargo
Capital One price target raised to $100 from $90 at Wells Fargo
10/09/20 JPMorgan
Capital One price target raised to $86.50 from $72 at JPMorgan
07/31/20 Wolfe Research
Capital One initiated with an Outperform at Wolfe Research
STX Seagate
$50.73 /

-1.07 (-2.07%)

10/23/20 Craig-Hallum
Seagate price target raised to $65 from $60 at Craig-Hallum
10/23/20 Loop Capital
Seagate price target raised to $60 from $55 at Loop Capital
10/23/20 Susquehanna
Seagate price target raised to $40 from $37 at Susquehanna
LLNW Limelight Networks
$4.37 /

-1.815 (-29.37%)

10/23/20 Craig-Hallum
Limelight Networks downgraded to Hold from Buy at Craig-Hallum
10/23/20 B. Riley Securities
Limelight Networks price target lowered to $7 from $9 at B. Riley Securities
10/23/20 Northland
Limelight Networks downgraded to Market Perform from Outperform at Northland
10/15/20 DA Davidson
Fastly price target lowered to $105 from $115 at DA Davidson
BLMN Bloomin' Brands
$15.65 /

-2.07 (-11.68%)

10/20/20 JPMorgan
Bloomin' Brands price target raised to $20 from $16 at JPMorgan
09/14/20 Raymond James
Bloomin' Brands price target raised to $20 from $18 at Raymond James
09/01/20
Fly Intel: Top five analyst upgrades
09/01/20 Raymond James
Raymond James upgrades casual restaurant laggard Bloomin' Brands to Strong Buy
STX Seagate
$50.73 /

-1.07 (-2.07%)

NVDA Nvidia
$537.90 /

+4.08 (+0.76%)

MAT Mattel
$14.51 /

+1.58 (+12.22%)

LLNW Limelight Networks
$4.37 /

-1.815 (-29.37%)

INTC Intel
$48.06 /

-5.92 (-10.97%)

GILD Gilead
$61.44 /

+0.76 (+1.25%)

COF Capital One
$77.64 /

+0.66 (+0.86%)

BLMN Bloomin' Brands
$15.65 /

-2.07 (-11.68%)

BCS Barclays
$5.78 /

+0.28 (+5.09%)

AXP American Express
$101.55 /

-3.25 (-3.10%)

AMD AMD
$81.05 /

+1.63 (+2.05%)

STX Seagate
$50.73 /

-1.07 (-2.07%)

NVDA Nvidia
$537.90 /

+4.08 (+0.76%)

INTC Intel
$48.06 /

-5.92 (-10.97%)

GILD Gilead
$61.44 /

+0.76 (+1.25%)

COF Capital One
$77.64 /

+0.66 (+0.86%)

BCS Barclays
$5.78 /

+0.28 (+5.09%)

AXP American Express
$101.55 /

-3.25 (-3.10%)

AMD AMD
$81.05 /

+1.63 (+2.05%)

STX Seagate
$50.73 /

-1.07 (-2.07%)

NVDA Nvidia
$537.90 /

+4.08 (+0.76%)

MAT Mattel
$14.51 /

+1.58 (+12.22%)

LLNW Limelight Networks
$4.37 /

-1.815 (-29.37%)

INTC Intel
$48.06 /

-5.92 (-10.97%)

GILD Gilead
$61.44 /

+0.76 (+1.25%)

COF Capital One
$77.64 /

+0.66 (+0.86%)

BLMN Bloomin' Brands
$15.65 /

-2.07 (-11.68%)

BCS Barclays
$5.78 /

+0.28 (+5.09%)

AXP American Express
$101.55 /

-3.25 (-3.10%)

AMD AMD
$81.05 /

+1.63 (+2.05%)

STX Seagate
$50.73 /

-1.07 (-2.07%)

NVDA Nvidia
$537.90 /

+4.08 (+0.76%)

MAT Mattel
$14.51 /

+1.58 (+12.22%)

LLNW Limelight Networks
$4.37 /

-1.815 (-29.37%)

INTC Intel
$48.06 /

-5.92 (-10.97%)

GILD Gilead
$61.44 /

+0.76 (+1.25%)

COF Capital One
$77.64 /

+0.66 (+0.86%)

BLMN Bloomin' Brands
$15.65 /

-2.07 (-11.68%)

BCS Barclays
$5.78 /

+0.28 (+5.09%)

AXP American Express
$101.55 /

-3.25 (-3.10%)

AMD AMD
$81.05 /

+1.63 (+2.05%)

Hot Stocks
Gilead completes acquisition of Immunomedics for $21B in aggregate » 10:15
10/23/20
10/23
10:15
10/23/20
10:15
GILD

Gilead

$63.39 /

+2.71 (+4.47%)

, IMMU

Acquired by GILD

$87.86 /

+ (+0.00%)

Gilead Sciences (GILD)…

Gilead Sciences (GILD) announced the completion of the previously announced transaction to acquire Immunomedics (IMMU) for approximately $21B in the aggregate. "We are very pleased to reach today's milestone and to welcome the talented Immunomedics team to the Gilead family. There is a lot of important work ahead of us to deliver on the vast potential that Trodelvy offers for patients with cancer," said Daniel O'Day, Chairman and CEO, Gilead Sciences. "Together we will bring Trodelvy to many more patients around the world with triple-negative breast cancer and continue to explore its potential in many other types of cancer, both as a monotherapy and in combination with other treatments." As a result of the completion of the merger, Immunomedics has become a wholly owned subsidiary of Gilead and the common stock of Immunomedics will no longer be listed for trading on the Nasdaq Global Market, which is expected to take effect as of the close of market on October 23, 2020.

ShowHide Related Items >><<
IMMU Acquired by GILD
$87.86 /

+ (+0.00%)

GILD Gilead
$63.39 /

+2.71 (+4.47%)

GILD Gilead
$63.39 /

+2.71 (+4.47%)

10/22/20 Piper Sandler
Approval of Gilead's Veklury confirms FDA confidence, says Piper Sandler
10/16/20 Baird
Baird negative on Gilead clinical data for remdesivir
10/16/20 Citi
Gilead investors may start questioning Galapagos collaboration, says Citi
09/30/20 Jefferies
Regeneron antibody cocktail results positive for vaccines, says Jefferies
IMMU Acquired by GILD
$87.86 /

+ (+0.00%)

09/21/20 BofA
Axalta Coating added to US 1 List at BofA
09/20/20 Citi
Immunomedics presents at ESMO, readouts exceeded expectations, says Citi
09/20/20 Piper Sandler
Immunomedics ASCENT data 'an absolute slam dunk,' says Piper Sandler
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
IMMU Acquired by GILD
$87.86 /

+ (+0.00%)

GILD Gilead
$63.39 /

+2.71 (+4.47%)

  • 29
    Apr
  • 05
    Dec
GILD Gilead
$63.39 /

+2.71 (+4.47%)

IMMU Acquired by GILD
$87.86 /

+ (+0.00%)

GILD Gilead
$63.39 /

+2.71 (+4.47%)

IMMU Acquired by GILD
$87.86 /

+ (+0.00%)

GILD Gilead
$63.39 /

+2.71 (+4.47%)

Options
Early notable gainers among liquid option names on October 23rd » 09:55
10/23/20
10/23
09:55
10/23/20
09:55
MAT

Mattel

$14.26 /

+1.33 (+10.29%)

, COF

Capital One

$79.52 /

+2.54 (+3.30%)

, VLO

Valero

$42.95 /

+1.66 (+4.02%)

, GILD

Gilead

$62.88 /

+2.2 (+3.63%)

, DGX

Quest Diagnostics

$128.76 /

+2.38 (+1.88%)

Notable gainers among…

Notable gainers among liquid option names this morning include Mattel (MAT) $14.26 +1.30, Capital One (COF) $79.84 +3.09, Valero (VLO) $42.91 +1.63, Gilead (GILD) $62.94 +2.26, and Quest Diagnostics (DGX) $130.40 +4.06.

ShowHide Related Items >><<
VLO Valero
$42.95 /

+1.66 (+4.02%)

MAT Mattel
$14.26 /

+1.33 (+10.29%)

GILD Gilead
$62.88 /

+2.2 (+3.63%)

DGX Quest Diagnostics
$128.76 /

+2.38 (+1.88%)

COF Capital One
$79.52 /

+2.54 (+3.30%)

MAT Mattel
$14.26 /

+1.33 (+10.29%)

10/23/20 JPMorgan
Mattel price target raised to $20 from $17.50 at JPMorgan
10/23/20 JPMorgan
Hasbro price target raised to $92 from $83 at JPMorgan
10/23/20 DA Davidson
Mattel upgraded to Buy at DA Davidson after 'outstanding' Q3 results
10/23/20 DA Davidson
Mattel upgraded to Buy from Neutral at DA Davidson
COF Capital One
$79.52 /

+2.54 (+3.30%)

10/23/20 RBC Capital
Capital One price target raised to $82 from $72 at RBC Capital
10/23/20 Wells Fargo
Capital One price target raised to $100 from $90 at Wells Fargo
10/09/20 JPMorgan
Capital One price target raised to $86.50 from $72 at JPMorgan
07/31/20 Wolfe Research
Capital One initiated with an Outperform at Wolfe Research
VLO Valero
$42.95 /

+1.66 (+4.02%)

10/22/20 Roth Capital
Darling Ingredients price target raised to $84 from $38 at Roth Capital
10/22/20 Mizuho
Valero price target lowered to $50 from $80 at Mizuho
10/06/20 Barclays
Valero price target lowered to $62 from $71 at Barclays
10/01/20
Fly Intel: Top five analyst downgrades
GILD Gilead
$62.88 /

+2.2 (+3.63%)

10/22/20 Piper Sandler
Approval of Gilead's Veklury confirms FDA confidence, says Piper Sandler
10/16/20 Baird
Baird negative on Gilead clinical data for remdesivir
10/16/20 Citi
Gilead investors may start questioning Galapagos collaboration, says Citi
09/30/20 Jefferies
Regeneron antibody cocktail results positive for vaccines, says Jefferies
DGX Quest Diagnostics
$128.76 /

+2.38 (+1.88%)

10/21/20 Argus
Quest Diagnostics upgraded to Buy from Hold at Argus
10/21/20 Argus
Quest Diagnostics upgraded to Buy from Hold at Argus
10/16/20 Baird
Baird 'pounding the table' on lab stocks after 'favorable' CMS update
10/14/20 Jefferies
Quest Diagnostics price target raised to $134 from $125 at Jefferies
VLO Valero
$42.95 /

+1.66 (+4.02%)

MAT Mattel
$14.26 /

+1.33 (+10.29%)

GILD Gilead
$62.88 /

+2.2 (+3.63%)

DGX Quest Diagnostics
$128.76 /

+2.38 (+1.88%)

COF Capital One
$79.52 /

+2.54 (+3.30%)

VLO Valero
$42.95 /

+1.66 (+4.02%)

GILD Gilead
$62.88 /

+2.2 (+3.63%)

DGX Quest Diagnostics
$128.76 /

+2.38 (+1.88%)

COF Capital One
$79.52 /

+2.54 (+3.30%)

VLO Valero
$42.95 /

+1.66 (+4.02%)

MAT Mattel
$14.26 /

+1.33 (+10.29%)

GILD Gilead
$62.88 /

+2.2 (+3.63%)

DGX Quest Diagnostics
$128.76 /

+2.38 (+1.88%)

COF Capital One
$79.52 /

+2.54 (+3.30%)

VLO Valero
$42.95 /

+1.66 (+4.02%)

MAT Mattel
$14.26 /

+1.33 (+10.29%)

GILD Gilead
$62.88 /

+2.2 (+3.63%)

DGX Quest Diagnostics
$128.76 /

+2.38 (+1.88%)

COF Capital One
$79.52 /

+2.54 (+3.30%)

Options
Unusually active option classes on open October 23rd » 09:40
10/23/20
10/23
09:40
10/23/20
09:40
GILD

Gilead

$60.68 /

+ (+0.00%)

, AXP

American Express

$104.80 /

+ (+0.00%)

, SNOW

Snowflake

$297.25 /

+0.76 (+0.26%)

, EMB

iShares JP Morgan USD Emerging Markets Bond ETF

$110.47 /

+ (+0.00%)

, FSLY

Fastly

$79.12 /

-0.13 (-0.16%)

, LYFT

Lyft

$25.59 /

+ (+0.00%)

, KRE

SPDR S&P Regional Banking ETF

$42.12 /

+ (+0.00%)

, GE

General Electric

$7.73 /

+ (+0.00%)

, CLF

Cleveland-Cliffs

$8.28 /

+ (+0.00%)

, M

Macy's

$7.01 /

+ (+0.00%)

Unusual total active…

Unusual total active option classes on open include: Gilead (GILD), American Express (AXP), Snowflake (SNOW), iShares Emerging Markets Bond ETF (EMB), Fastly Inc (FSLY), Lyft (LYFT), SPDR S&P Regional Banking (KRE), General Electric (GE), Cleveland-Cliffs (CLF), and Macy's (M).

ShowHide Related Items >><<
SNOW Snowflake
$297.25 /

+0.76 (+0.26%)

M Macy's
$7.01 /

+ (+0.00%)

LYFT Lyft
$25.59 /

+ (+0.00%)

GILD Gilead
$60.68 /

+ (+0.00%)

GE General Electric
$7.73 /

+ (+0.00%)

FSLY Fastly
$79.12 /

-0.13 (-0.16%)

CLF Cleveland-Cliffs
$8.28 /

+ (+0.00%)

AXP American Express
$104.80 /

+ (+0.00%)

GILD Gilead
$60.68 /

+ (+0.00%)

10/22/20 Piper Sandler
Approval of Gilead's Veklury confirms FDA confidence, says Piper Sandler
10/16/20 Baird
Baird negative on Gilead clinical data for remdesivir
10/16/20 Citi
Gilead investors may start questioning Galapagos collaboration, says Citi
09/30/20 Jefferies
Regeneron antibody cocktail results positive for vaccines, says Jefferies
AXP American Express
$104.80 /

+ (+0.00%)

10/09/20
Fly Intel: Top five analyst downgrades
10/09/20 JPMorgan
American Express price target raised to $106 from $97 at JPMorgan
10/09/20 Susquehanna
American Express downgraded to Neutral from Positive at Susquehanna
09/23/20
Fly Intel: Top five analyst downgrades
SNOW Snowflake
$297.25 /

+0.76 (+0.26%)

10/13/20 Citi
Snowflake initiated with a Neutral at Citi
10/12/20
Fly Intel: Top five analyst initiations
10/12/20 Loop Capital
Snowflake initiated with a Hold at Loop Capital
10/12/20 Canaccord
Snowflake initiated with a Hold at Canaccord
EMB iShares JP Morgan USD Emerging Markets Bond ETF
$110.47 /

+ (+0.00%)

FSLY Fastly
$79.12 /

-0.13 (-0.16%)

10/23/20 Piper Sandler
Piper downgrades Fastly to Underweight with TikTok becoming 'bigger issue'
10/23/20 Piper Sandler
Fastly downgraded to Underweight from Neutral at Piper Sandler
10/16/20 Craig-Hallum
Fastly price target lowered to $85 from $100 at Craig-Hallum
10/15/20
Fly Intel: Top five analyst downgrades
LYFT Lyft
$25.59 /

+ (+0.00%)

09/25/20 JPMorgan
Lyft price target lowered to $38 from $41 at JPMorgan
08/28/20 Piper Sandler
Piper 'bearishly inclined' on Uber, Lyft shares into November election
08/24/20 Loop Capital
Uber price target lowered to $40 from $43 at Loop Capital
08/20/20 JPMorgan
Rideshare increasingly likely to shut down in California, says JPMorgan
KRE SPDR S&P Regional Banking ETF
$42.12 /

+ (+0.00%)

GE General Electric
$7.73 /

+ (+0.00%)

10/13/20 Deutsche Bank
General Electric price target raised to $6.81 from $6.25 at Deutsche Bank
10/09/20 Goldman Sachs
Goldman sees 50% upside in General Electric, reinstates shares at Buy
09/17/20 JPMorgan
Those calling GE guidance 'inflection' misunderstand business, says JPMorgan
08/31/20 JPMorgan
JPMorgan's Tusa withdraws GE price target, sees fair value below $5
CLF Cleveland-Cliffs
$8.28 /

+ (+0.00%)

09/29/20 Citi
Cleveland-Cliffs acquisition positive for company, industry, says Citi
09/14/20 B. Riley Securities
Cleveland-Cliffs a 'compelling contrarian opportunity,' says B. Riley FBR
07/31/20 GLJ Research
Cleveland-Cliffs downgraded to Sell from Hold at GLJ Research
06/03/20 GLJ Research
Cleveland-Cliffs upgraded to Hold from Sell at GLJ Research
M Macy's
$7.01 /

+ (+0.00%)

10/14/20 Morgan Stanley
Morgan Stanley, despite 'positive view' of new Macy's CFO, stays Underweight
09/04/20 Credit Suisse
No signs of improvement ahead for Macy's after 'solid' Q2, says Credit Suisse
09/03/20 Deutsche Bank
Macy's price target raised to $7 from $6 at Deutsche Bank
09/02/20 Goldman Sachs
Macy's still faces 'significant risks', says Goldman Sachs
M Macy's
$7.01 /

+ (+0.00%)

LYFT Lyft
$25.59 /

+ (+0.00%)

GILD Gilead
$60.68 /

+ (+0.00%)

GE General Electric
$7.73 /

+ (+0.00%)

FSLY Fastly
$79.12 /

-0.13 (-0.16%)

CLF Cleveland-Cliffs
$8.28 /

+ (+0.00%)

AXP American Express
$104.80 /

+ (+0.00%)

  • 16
    Sep
  • 21
    May
SNOW Snowflake
$297.25 /

+0.76 (+0.26%)

M Macy's
$7.01 /

+ (+0.00%)

LYFT Lyft
$25.59 /

+ (+0.00%)

GILD Gilead
$60.68 /

+ (+0.00%)

GE General Electric
$7.73 /

+ (+0.00%)

CLF Cleveland-Cliffs
$8.28 /

+ (+0.00%)

AXP American Express
$104.80 /

+ (+0.00%)

SNOW Snowflake
$297.25 /

+0.76 (+0.26%)

M Macy's
$7.01 /

+ (+0.00%)

LYFT Lyft
$25.59 /

+ (+0.00%)

GILD Gilead
$60.68 /

+ (+0.00%)

GE General Electric
$7.73 /

+ (+0.00%)

FSLY Fastly
$79.12 /

-0.13 (-0.16%)

CLF Cleveland-Cliffs
$8.28 /

+ (+0.00%)

AXP American Express
$104.80 /

+ (+0.00%)

SNOW Snowflake
$297.25 /

+0.76 (+0.26%)

M Macy's
$7.01 /

+ (+0.00%)

LYFT Lyft
$25.59 /

+ (+0.00%)

KRE SPDR S&P Regional Banking ETF
$42.12 /

+ (+0.00%)

GILD Gilead
$60.68 /

+ (+0.00%)

GE General Electric
$7.73 /

+ (+0.00%)

FSLY Fastly
$79.12 /

-0.13 (-0.16%)

EMB iShares JP Morgan USD Emerging Markets Bond ETF
$110.47 /

+ (+0.00%)

CLF Cleveland-Cliffs
$8.28 /

+ (+0.00%)

AXP American Express
$104.80 /

+ (+0.00%)

EMB iShares JP Morgan USD Emerging Markets Bond ETF
$110.47 /

+ (+0.00%)

On The Fly
Fly Intel: Pre-market Movers » 08:56
10/23/20
10/23
08:56
10/23/20
08:56
GILD

Gilead

$60.68 /

+0.44 (+0.73%)

, CNX

CNX Resources

$11.50 /

+1.19 (+11.54%)

, FHN

First Horizon

$11.45 /

+0.6 (+5.53%)

, BLMN

Bloomin' Brands

$17.72 /

+0.63 (+3.69%)

, MAT

Mattel

$12.93 /

+0.475 (+3.81%)

, COF

Capital One

$76.98 /

+3.24 (+4.39%)

, AXP

American Express

$104.80 /

+3.34 (+3.29%)

, LLNW

Limelight Networks

$6.18 /

+0.05 (+0.82%)

, INTC

Intel

$53.98 /

+0.49 (+0.92%)

, STX

Seagate

$51.80 /

+0.06 (+0.12%)

, MIST

Milestone Pharmaceuticals

$6.99 /

+0.18 (+2.64%)

, LGND

Ligand

$84.89 /

+4.56 (+5.68%)

Check out this morning's…

ShowHide Related Items >><<
STX Seagate
$51.80 /

+0.06 (+0.12%)

MIST Milestone Pharmaceuticals
$6.99 /

+0.18 (+2.64%)

MAT Mattel
$12.93 /

+0.475 (+3.81%)

LLNW Limelight Networks
$6.18 /

+0.05 (+0.82%)

LGND Ligand
$84.89 /

+4.56 (+5.68%)

INTC Intel
$53.98 /

+0.49 (+0.92%)

GILD Gilead
$60.68 /

+0.44 (+0.73%)

FHN First Horizon
$11.45 /

+0.6 (+5.53%)

COF Capital One
$76.98 /

+3.24 (+4.39%)

CNX CNX Resources
$11.50 /

+1.19 (+11.54%)

BLMN Bloomin' Brands
$17.72 /

+0.63 (+3.69%)

AXP American Express
$104.80 /

+3.34 (+3.29%)

GILD Gilead
$60.68 /

+0.44 (+0.73%)

10/22/20 Piper Sandler
Approval of Gilead's Veklury confirms FDA confidence, says Piper Sandler
10/16/20 Baird
Baird negative on Gilead clinical data for remdesivir
10/16/20 Citi
Gilead investors may start questioning Galapagos collaboration, says Citi
09/30/20 Jefferies
Regeneron antibody cocktail results positive for vaccines, says Jefferies
CNX CNX Resources
$11.50 /

+1.19 (+11.54%)

10/08/20 Stifel
CNX Resources resumed with a Buy at Stifel
09/23/20 Capital One
CNX Resources initiated with an Overweight at Capital One
08/17/20
Fly Intel: Top five analyst downgrades
08/17/20 MKM Partners
CNX Resources downgraded to Neutral from Buy at MKM Partners
FHN First Horizon
$11.45 /

+0.6 (+5.53%)

10/08/20 Jefferies
First Horizon upgraded to Buy from Hold at Jefferies
09/22/20 Raymond James
First Horizon upgraded to Strong Buy from Outperform at Raymond James
08/20/20 Goldman Sachs
First Horizon reinstated with a Buy at Goldman Sachs
08/17/20 Morgan Stanley
First Horizon resumed with an Equal Weight at Morgan Stanley
BLMN Bloomin' Brands
$17.72 /

+0.63 (+3.69%)

10/20/20 JPMorgan
Bloomin' Brands price target raised to $20 from $16 at JPMorgan
09/14/20 Raymond James
Bloomin' Brands price target raised to $20 from $18 at Raymond James
09/01/20
Fly Intel: Top five analyst upgrades
09/01/20 Raymond James
Raymond James upgrades casual restaurant laggard Bloomin' Brands to Strong Buy
MAT Mattel
$12.93 /

+0.475 (+3.81%)

10/23/20 JPMorgan
Mattel price target raised to $20 from $17.50 at JPMorgan
10/23/20 JPMorgan
Hasbro price target raised to $92 from $83 at JPMorgan
10/23/20 DA Davidson
Mattel upgraded to Buy at DA Davidson after 'outstanding' Q3 results
10/23/20 DA Davidson
Mattel upgraded to Buy from Neutral at DA Davidson
COF Capital One
$76.98 /

+3.24 (+4.39%)

10/23/20 RBC Capital
Capital One price target raised to $82 from $72 at RBC Capital
10/23/20 Wells Fargo
Capital One price target raised to $100 from $90 at Wells Fargo
10/09/20 JPMorgan
Capital One price target raised to $86.50 from $72 at JPMorgan
07/31/20 Wolfe Research
Capital One initiated with an Outperform at Wolfe Research
AXP American Express
$104.80 /

+3.34 (+3.29%)

10/09/20
Fly Intel: Top five analyst downgrades
10/09/20 JPMorgan
American Express price target raised to $106 from $97 at JPMorgan
10/09/20 Susquehanna
American Express downgraded to Neutral from Positive at Susquehanna
09/23/20
Fly Intel: Top five analyst downgrades
LLNW Limelight Networks
$6.18 /

+0.05 (+0.82%)

10/23/20 Craig-Hallum
Limelight Networks downgraded to Hold from Buy at Craig-Hallum
10/23/20 B. Riley Securities
Limelight Networks price target lowered to $7 from $9 at B. Riley Securities
10/23/20 Northland
Limelight Networks downgraded to Market Perform from Outperform at Northland
10/15/20 DA Davidson
Fastly price target lowered to $105 from $115 at DA Davidson
INTC Intel
$53.98 /

+0.49 (+0.92%)

10/23/20 Jefferies
TSMC clearly has 'stronger hand' if Intel comes to negotiate, says Jefferies
10/23/20 JPMorgan
Intel price target lowered to $70 from $75 at JPMorgan
10/23/20 UBS
Intel price target lowered to $62 from $67 at UBS
10/23/20 Morgan Stanley
Intel price target lowered to $56 from $61 at Morgan Stanley
STX Seagate
$51.80 /

+0.06 (+0.12%)

10/23/20 Craig-Hallum
Seagate price target raised to $65 from $60 at Craig-Hallum
10/23/20 Loop Capital
Seagate price target raised to $60 from $55 at Loop Capital
10/23/20 Susquehanna
Seagate price target raised to $40 from $37 at Susquehanna
10/23/20 Benchmark
Seagate upgraded to Buy after earnings at Benchmark
MIST Milestone Pharmaceuticals
$6.99 /

+0.18 (+2.64%)

07/29/20 Oppenheimer
Oppenheimer upgrades Milestone to Outperform on 'best-case' FDA outcome
07/29/20 Oppenheimer
Milestone Pharmaceuticals upgraded to Outperform from Perform at Oppenheimer
07/24/20
Fly Intel: Top five analyst upgrades
07/24/20 Jefferies
Jefferies upgrades Milestone to Buy on 'major' FDA win
LGND Ligand
$84.89 /

+4.56 (+5.68%)

10/21/20 Craig-Hallum
Ligand price target lowered to $195 from $215 at Craig-Hallum
10/06/20 Barclays
Ligand reinstated with an Overweight at Barclays
09/29/20 Roth Capital
Ligand price target raised to $195 from $190 at Roth Capital
09/23/20 H.C. Wainwright
H.C. Wainwright reiterates $229 target on Ligand after Captisol boost
STX Seagate
$51.80 /

+0.06 (+0.12%)

MIST Milestone Pharmaceuticals
$6.99 /

+0.18 (+2.64%)

MAT Mattel
$12.93 /

+0.475 (+3.81%)

LLNW Limelight Networks
$6.18 /

+0.05 (+0.82%)

LGND Ligand
$84.89 /

+4.56 (+5.68%)

INTC Intel
$53.98 /

+0.49 (+0.92%)

GILD Gilead
$60.68 /

+0.44 (+0.73%)

FHN First Horizon
$11.45 /

+0.6 (+5.53%)

COF Capital One
$76.98 /

+3.24 (+4.39%)

CNX CNX Resources
$11.50 /

+1.19 (+11.54%)

BLMN Bloomin' Brands
$17.72 /

+0.63 (+3.69%)

AXP American Express
$104.80 /

+3.34 (+3.29%)

  • 23
    Oct
  • 20
    Nov
STX Seagate
$51.80 /

+0.06 (+0.12%)

INTC Intel
$53.98 /

+0.49 (+0.92%)

GILD Gilead
$60.68 /

+0.44 (+0.73%)

COF Capital One
$76.98 /

+3.24 (+4.39%)

CNX CNX Resources
$11.50 /

+1.19 (+11.54%)

AXP American Express
$104.80 /

+3.34 (+3.29%)

STX Seagate
$51.80 /

+0.06 (+0.12%)

MIST Milestone Pharmaceuticals
$6.99 /

+0.18 (+2.64%)

MAT Mattel
$12.93 /

+0.475 (+3.81%)

LLNW Limelight Networks
$6.18 /

+0.05 (+0.82%)

LGND Ligand
$84.89 /

+4.56 (+5.68%)

INTC Intel
$53.98 /

+0.49 (+0.92%)

GILD Gilead
$60.68 /

+0.44 (+0.73%)

FHN First Horizon
$11.45 /

+0.6 (+5.53%)

COF Capital One
$76.98 /

+3.24 (+4.39%)

CNX CNX Resources
$11.50 /

+1.19 (+11.54%)

BLMN Bloomin' Brands
$17.72 /

+0.63 (+3.69%)

AXP American Express
$104.80 /

+3.34 (+3.29%)

STX Seagate
$51.80 /

+0.06 (+0.12%)

MIST Milestone Pharmaceuticals
$6.99 /

+0.18 (+2.64%)

MAT Mattel
$12.93 /

+0.475 (+3.81%)

LLNW Limelight Networks
$6.18 /

+0.05 (+0.82%)

INTC Intel
$53.98 /

+0.49 (+0.92%)

GILD Gilead
$60.68 /

+0.44 (+0.73%)

COF Capital One
$76.98 /

+3.24 (+4.39%)

CNX CNX Resources
$11.50 /

+1.19 (+11.54%)

BLMN Bloomin' Brands
$17.72 /

+0.63 (+3.69%)

AXP American Express
$104.80 /

+3.34 (+3.29%)

Hot Stocks
Ligand highlights role in manufacturing Gilead Veklury » 08:35
10/23/20
10/23
08:35
10/23/20
08:35
LGND

Ligand

$84.89 /

+4.56 (+5.68%)

, GILD

Gilead

$60.68 /

+0.44 (+0.73%)

Ligand (LGND) highlighted…

Ligand (LGND) highlighted the company's role in the manufacturing of Veklury, Gilead's (GILD) antiviral drug for the treatment of patients with COVID-19 requiring hospitalization. Veklury is formulated with Ligand's Captisol technology. Approved yesterday by the FDA, Veklury is the first and only approved COVID-19 treatment in the United States. The drug is now widely available in hospitals across the country, following Gilead's early investments to rapidly expand manufacturing capacity to increase supply. "We congratulate Gilead on achieving this regulatory milestone," said John Higgins, CEO of Ligand. "Veklury is an important medicine that has already played a vital role in the treatment of many patients with COVID-19 worldwide. In early January Gilead contacted Ligand requesting urgent shipments of Captisol. Over the following weeks and months, the Captisol volume requirements and supply needs expanded significantly, and Ligand has been there to support Gilead in their effort to manufacture millions of treatment courses. While the progression of the pandemic was and still is unknown, Ligand made the strategic and ethical decision to invest significantly in scale-up to ensure we had sufficient capacity to meet the Captisol supply needs for Gilead and members of its international manufacturing consortium. It has been an intense nine months executing on these efforts. We are proud of our contribution to this first and only U.S.-approved treatment for COVID-19, and we are equally proud of our ability to execute so efficiently and smoothly to answer the call."

ShowHide Related Items >><<
LGND Ligand
$84.89 /

+4.56 (+5.68%)

GILD Gilead
$60.68 /

+0.44 (+0.73%)

LGND Ligand
$84.89 /

+4.56 (+5.68%)

10/21/20 Craig-Hallum
Ligand price target lowered to $195 from $215 at Craig-Hallum
10/06/20 Barclays
Ligand reinstated with an Overweight at Barclays
09/29/20 Roth Capital
Ligand price target raised to $195 from $190 at Roth Capital
09/23/20 H.C. Wainwright
H.C. Wainwright reiterates $229 target on Ligand after Captisol boost
GILD Gilead
$60.68 /

+0.44 (+0.73%)

10/22/20 Piper Sandler
Approval of Gilead's Veklury confirms FDA confidence, says Piper Sandler
10/16/20 Baird
Baird negative on Gilead clinical data for remdesivir
10/16/20 Citi
Gilead investors may start questioning Galapagos collaboration, says Citi
09/30/20 Jefferies
Regeneron antibody cocktail results positive for vaccines, says Jefferies
LGND Ligand
$84.89 /

+4.56 (+5.68%)

GILD Gilead
$60.68 /

+0.44 (+0.73%)

GILD Gilead
$60.68 /

+0.44 (+0.73%)

LGND Ligand
$84.89 /

+4.56 (+5.68%)

GILD Gilead
$60.68 /

+0.44 (+0.73%)

GILD Gilead
$60.68 /

+0.44 (+0.73%)

Thursday
Recommendations
Approval of Gilead's Veklury confirms FDA confidence, says Piper Sandler » 19:36
10/22/20
10/22
19:36
10/22/20
19:36
GILD

Gilead

$60.68 /

+0.44 (+0.73%)

Piper Sandler analyst…

Piper Sandler analyst Tyler Van Buren keeps his Overweight rating and $95 price target on Gilead after the FDA announced that it has granted a full approval for Veklury, or remdesivir, in treatment of COVID-19. The analyst says the decision signals the FDA's confidence in the ACTT-1 study results, while its EUA on pediatric use highlights its comfort regarding the drug's safety. Van Buren adds that he would be "curious to learn more about post-marketing requirements that have been agreed upon", though regardless of the terms, the analyst contends that the drug could generate over $1B in sales for Gilead during the second half of the year assuming the current case rate.

ShowHide Related Items >><<
GILD Gilead
$60.68 /

+0.44 (+0.73%)

GILD Gilead
$60.68 /

+0.44 (+0.73%)

10/16/20 Baird
Baird negative on Gilead clinical data for remdesivir
10/16/20 Citi
Gilead investors may start questioning Galapagos collaboration, says Citi
09/30/20 Jefferies
Regeneron antibody cocktail results positive for vaccines, says Jefferies
09/24/20 H.C. Wainwright
Durect study designed to support full approval, says H.C. Wainwright
GILD Gilead
$60.68 /

+0.44 (+0.73%)

GILD Gilead
$60.68 /

+0.44 (+0.73%)

GILD Gilead
$60.68 /

+0.44 (+0.73%)

GILD Gilead
$60.68 /

+0.44 (+0.73%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.